15280 Characterization of super responders to guselkumab treatment in moderate to severe psoriasis: Results from the VOYAGE 1 and 2 clinical trials

https://doi.org/10.1016/j.jaad.2020.06.668Get rights and content

References (0)

Cited by (0)

Commercial disclosure: This study was sponsored by Janssen Research & Development.

View full text